Recent approaches in design of peptidomimetics for antimicrobial drug discovery research

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 7, 2013, Pages 1073-1088

  Lohan, Sandeep ^a   Bisht, Gopal Singh ^a  

^a JAYPEE UNIVERSITY OF INFORMATION TECHNOLOGY   (India)

Author keywords

Antibiotics resistance; Cationic antimicrobial peptides; Peptidomimetics; Synthetic mimics of antimicrobial peptides (SMAMPs)

Indexed keywords

BRILACIDIN; CIPROFLOXACIN; NORFLOXACIN; PEPTIDOMIMETIC AGENT; PEPTOID; PEXIGANAN; POLYMER; POLYPEPTIDE ANTIBIOTIC AGENT;

ANTIMICROBIAL ACTIVITY; CHEMICAL STRUCTURE; CLINICAL TRIAL (TOPIC); CYCLIZATION; DRUG DESIGN; DRUG SELECTIVITY; DRUG STRUCTURE; HEMOLYSIS; HUMAN; HYDROGEN BOND; HYDROPHOBICITY; IMMUNE SYSTEM; IMMUNOGENICITY; LIPOPHILICITY; MOLECULAR DYNAMICS; MOLECULAR WEIGHT; PHYSICAL CHEMISTRY; PROTEIN DEGRADATION; REVIEW; SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; DRUG DESIGN; DRUG DISCOVERY; FUNGI; HUMANS; PEPTIDOMIMETICS;

EID: 84878640809     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/1389557511313070010     Document Type: Review

References (120)

1. Cherkasov, A.; Hilpert, K.; Jenssen, H.; Fjell, C.D.; Waldbrook, M.; Mullaly, S.C.; Volkmer, R.; Hancock, R.E. Use of artificial intelligence in the design of small peptide antibiotics effective against a broad spectrum of highly antibiotic-resistant superbugs. ACS Chem. Biol., 2008, 4(1), 65-74.
2. Karthikeyan, K.K.; Mark, A.T.; Timothy, R.W.; Jay, B.; Fafhana, B.; Ravikumar, B.; Uma, C.; Michel, D.; Christian, G.G.; Seema, I.; Padma, K.; Anil, V.K.; Sunil, M.; Shazad, M.; Tabassum, N.; David, L.P.; Andrew, P.; Claire, P.; Rachel, P.; Bhargavi, R.; Ujjwayini, R.; Jayanta, B.S.; Madhu, S.; Elizabeth, S.; Mandayam, A.T.; Jane, T.; Supriya, U.; Marina, W.; William, W.; David, M.L.; Neil, W. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect. Dis., 2010, 10(9), 597-602.
3. Cudic, M.; Condie, B.A.; Weiner, D.J.; Lysenko, E.S.; Xiang, Z.Q.; Sullivan, I.O.; Bulet, P.; Otvos, L. Development of novel antibacterial peptides that kill resistant isolates. Peptides, 2002, 23(12), 2071-2083.
4. Hooper D.C. Emerging mechanisms of fluoroquinolone resistance. Emerg. Infect. Dis., 2001, 7(2), 337-341.
5. Mwangi, M.M.; Wu, S.W.; Zhou, Y.; Sieradzki, K.; Lencastre, H.D.; Richardson, P.; Bruce, D.; Rubin, E.; Myers, E.; Siggia, E.D.; Tomasz, A. Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc. Natl. Acad. Sci. U.S.A., 2007, 104(22), 9451-9456.
6. Prachayasittikul, V.; Lawung, R.; Bulow, L. Episome profiles and mobilizable beta-lactamase plasmid in Haemophilus ducreyi. Southeast Asian J. Trop. Med. Public Health, 2000, 31(1), 80-84.
7. Spellberg, B.; Powers, J.H.; Brass, E.P.; Miller, L.G.; Edwards, J.E. Trends in antimicrobial drug development: implications for the future. Clin. Infect. Dis., 2004, 38(9), 1279-1286.
8. Toke, O. Antimicrobial peptides: New candidates in the Figureht against bacterial infections. Biopolymers, 2005, 80(6), 717-735.
9. Jenssen, H.; Hamill, P.; Hancock, R.E. Peptide antimicrobial agents. Clin. Microbiol. Rev., 2006, 19(3), 491-511.
10. Zasloff, M. Antimicrobial peptides of multicellular organisms, Nature, 2002, 415(6870), 389-395.
11. Steiner, H.; Hultmark, D.; Engstrom, A.; Bennich, H.; Boman, H.G. Sequence and specificity of two antibacterial proteins involved in insect immunity. Nature, 1981, 292(5820), 246-248.
12. Boman, H.G. Peptide antibiotics and their role in innate immunity. Annu. Rev. Immunol., 1995, 13, 61-92.
13. Hancock, R.E.W.; Lehrer, R. Cationic peptides: a new source of antibiotics. Trends Biotechnol., 1998, 16(2), 82-88.
14. Cederlund, A.; Gudmundsson, G.H.; Agerberth, B. Antimicrobial peptides important in innate immunity. FEBS J., 2011, 278(20), 3942-3951.
15. Giuliani, A.; Pirri, G.; Nicoletto, S.F. Antimicrobial peptides: an overview of a promising class of therapeutics. Cent. Eur. J. Biol., 2007, 2(1), 1-33.
16. Brogden, K.A.; Ackermann, M.; McCray, P.B. Tack, B.F. Antimicrobial peptides in animals and their role in host defences. Int. J. Antimicrob. Agents, 2003, 22(5), 465-478.
17. Lai, R.; Liu, H.; Lee, W.H.; Zhang, Y. An anionic antimicrobial peptide from toad Bombina maxima. Biochem. Biophys. Res. Comm., 2002, 295(4), 796-899.
18. Selsted, M.E.; Ouellette, A.J. Mammalian defensins in the antimicrobial immune response. Nat. Immunol., 2005, 6(6), 551-557.
19. Yeaman, M.R.; Yount, N.Y. Mechanisms of antimicrobial peptide action and resistance. Pharmacol. Rev., 2003, 55(1), 27-55.
20. Matsuzaki, K. Why and how are peptide-lipid interactions utilized for self-defense? Magainins and tachyplesins as archetypes. Biochim. Biophys. Acta, 1999, 1462(1-2), 1-10.
21. Brodgen, K.A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?. Nat. Rev. Microbiol., 2005, 3(3), 238-250.
22. Yang, L.; Mishra, A.; Purdy, K.; Som A.; Tew, G.N.; Wong, G.C.L. Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes. J. Am. Chem. Soc., 2007, 129(40), 12141-12147.
23. Wimley, W.; Hristova, K. Antimicrobial peptides: successes, challenges and unanswered questions. J. Membr. Biol. 2011, 239(1-2), 27-34.
24. Isaksson, J.; Brandsdal, B.O.; Engqvist, M.; Flaten, G.E.; Svendsen, J.S.; Stensen, W. A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption. J Med Chem., 2011, 54(16), 5786-5795.
25. Stromstedt, A.A.; Ringstad, L.; Schmidtchen, A.; Malmsten, M. Interaction between amphiphilic peptides and phospholipids membranes. Curr. Opin. Colloid Interface Sci., 2010, 15(6), 467-478.
26. Shai, Y.; Oren, Z. From "carpet" mechanism to de-novo designed diastereomeric cell-selective antimicrobial peptides. Peptides, 2001, 22(10), 1629-1641.
27. Murakami, T.; Nakajima, T.; Koyanagi, Y.; Tachibana, K.; Fujii, N.; Tamamura, H.; Yoshida, N.; Waki, M.; Matsumoto, A.; Yoshie, O.; Kishimoto, T.; Yamamoto, N.; Nagasawa T. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection. J. Exp. Med., 1997, 186(8), 1389-1393.
28. Sanderson, J.M. Peptide-lipids interactions: insights and perspectives. Org. Biomol. Chem., 2005, 3(2), 201-212.
29. Christensen, B.; Fink, J.; Merrifield, R.B.; Mauzerall, D.; Channel-forming properties of cecropins and related model compounds incorporated into planar lipid membranes. Proc. Natl. Acad. Sci. U. S. A., 1988, 85(14), 5072-5076.
30. Matsuzaki, K. Magainins as paradigm for the mode of action of pore forming polypeptides. Biochim. Biophys. Acta, 1998, 1376(3), 391-400.
31. Yang, L.; Harroun, T.A.; Weiss, T.M.; Ding, L.; Huang, H.W. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys. J., 2001, 81(3), 1475-1485.
32. Breukink, E.J.; De Kruijff, B. The lantibiotic nisin, a special case or not?. Biochim. Biophys. Acta, 1999, 1462(1-2), 223-234.
33. Beven, L.; Helluin, O.; Molle, G.; Duclohier, H.; Wroblewski, H. Correlation between anti-bacterial activity and pore sizes of two classes of voltage dependent channel-forming peptides. Biochim. Biophys. Acta, 1999, 1421(1), 53-63.
34. Yang, L.; Weiss, T.M.; Lehrer, R.I.; Huang, H.W. Crystallization of antimicrobial pores in membranes: magainin and protegrin. Biophys. J., 2001, 79(4), 2002-2009.
35. Matsuzaki, K.; Murase, O.; Fujii, N.; Miyajima, K. An antimicrobial peptide, magainin 2, induced rapid flip-flop of phospholipids coupled with pore formation and peptide translocation. Biochemistry, 1996, 35(35), 11361-11368.
36. Mangoni, M.L. Host-defense peptides: from biology to therapeutic strategies. Cell Mol Life Sci., 2011, 68(13), 2157-2159.
37. Giacometti, A.; Cirioni, O.; Barchiesi F.; Scalise, G. In-vitro activity and killing effect of polycationic peptides on methicillin-resistant Staphylococcus aureus and interactions with clinically used antibiotics. Diagn. Microbiol. Infect. Dis., 2000, 38(2), 115-118.
38. Ganz, T. Defensins and host defense. Science, 1999, 286(5439), 420-421.
39. Gallo R.L.; Ono M.; Povsic, T.; Page, C.; Eriksson, E.; Klagsbrun, M.; Bernfield, M. Syndecans, cell surface heparan sulfate proteoglycans, are induced by a proline-rich antimicrobial peptide from wounds. Proc. Natl. Acad. Sci. U.S.A., 1994, 91(23), 11035-11039.
40. Mor, A. Peptide-based antibiotics: A potential answer to raging antimicrobial resistance. Drug Dev. Res., 2000, 50(3-4), 440-447.
41. Perron, G.G.; Zasloff, M.; Bell, G. Experimental evolution of resistance to an antimicrobial peptide. Proc. Biol. Sci., 2006, 273(1583), 251-256.
42. Haynie, S.L.; Crum G.A.; Doele, B.A. Antimicrobial activities of amphiphilic peptides covalently bonded to a water-insoluble resin. Antimicrob. Agents Chemother., 1995, 39(2), 301-307.
43. Giuliani, A.; Rinaldi, A.C. Beyond natural antimicrobial peptides: multimeric peptides and other peptidomimetic approaches. Cell. Mol. Life Sci., 2011, 68(13), 2255-2266.
44. Habets, M.G.; Brockhurst, M.A. Therapeutic antimicrobial peptides may compromise natural immunity. Biol Lett., 2012, 8(3), 416-418.
45. Som, A.; Vemparala, S.; Ivanov, I.; Tew, G.N. Synthetic mimics of antimicrobial peptides. Biopolymers, 2008, 90(2), 83-93.
46. Vagner, J.; Qu H.; Hruby, V.J. Peptidomimetics, a synthetic tool of drug discovery. Curr. Opin. Chem. Biol., 2008, 12(3), 292-296.
47. Kirshenbaum, K.; Zuckermann, R.N.; Dill, K.A. Designing polymers that mimic biomolecules. Curr. Opin. Struct. Biol., 1999, 9(4), 530-535.
48. Barron, A.E.; Zuckermann, R.N. Bioinspired polymeric materials: in-between proteins and plastics. Curr. Opin. Chem. Biol., 1999, 3(6), 681-687.
49. Liskamp, R.M.; Rijkers, D.T.; Kruijtzer, J.A.; Kemmink, J. Peptides and proteins as a continuing exciting source of inspiration for peptidomimetics. Chem.Bio.Chem., 2011, 12(11), 1626-1653.
50. Chongsiriwatana, N.P.; Patch, J.A. Czyzewski, A.M. Peptoids that mimic the structure, function and mechanism of helical antimicrobial peptides. Proc. Natl. Acad. Sci. USA., 2008, 105(8), 2794-2799.
51. Wu, C.W.; Sanborn, T.J.; Huang, K.; Zuckermann, R.N.; Barron, A.E. Peptoid oligomers with a-chiral, aromatic side chains: sequence requirements for the formation of stable peptoid helices. J. Am. Chem. Soc., 2001, 123(28), 6778-6784.
52. Tew, G.N.; Scott, R.W.; Klein, M.L.; Degrado, W.F. De novo design of antimicrobial polymers, foldamers and small molecules: from discovery to practical applications. Acc. Chem. Res., 2010, 43(1), 30-39.
53. Scott, R.W.; DeGrado, W.F.; Tew, G.N. De novo designed synthetic mimics of antimicrobial peptides. Curr. Opin. Biotechnol, 2008, 19(6), 620-627.
54. Tew, G.N. Liu, D.; Chen, B.; Doerksen, R.J.; Kaplan, J.; Carroll, P.J. Klein M.L.; DeGrado, W.F. De novo design of biomimetic antimicrobial polymers. Proc. Natl. Acad. Sci. USA., 2002, 99(8), 5110-5114.
55. Simon, R.J.; Kania, R.S.; Zuckermann, R.N.; Huebner, V.D.; Jewell, D.A.; Banville, S.; Ng, S.; Wang, L.; Rosenberg, S.; Marlowe, C.K.; Spellmeyer, D.C.; Tan, R.; Frankel, A.D.; Santi, D.V.; Cohen, F.E.; Bartlett, P.A Peptoids: a modular approach to drug discovery. Proc. Natl. Acad. Sci. USA., 1992, 89(20), 9367-9371.
56. Zuckermann, R.N.; Kerr, J.M.; Kent, S.B.H.; Moos, W.H. Efficient method for the preparation of peptoids [oligo(N-substituted glycines)] by submonomer solid-phase synthesis. J. Am. Chem. Soc, 1992, 114, 10646-10647.
57. Miller, S.M.; Simon, R.J.; Ng, S.; Zuckermann, R.N.; Kerr, J.M.; Moos, W.H. Proteolytic studies of homologous peptide and N-substituted glycine peptoid oligomers. Bioorg. Med. Chem. Lett., 1994, 4, 2657-2662.
58. Miller, S.M.; Simon, R.J.; Ng, S.; Zuckermann, R.N.; Kerr, J.M.; Moos, W.H. Comparison of the proteolytic susceptibilities of homologous L-amino acid, D-amino acid, and N-substituted glycine peptide and peptoid oligomers. Drug Dev. Res., 1995, 35, 20-32.
59. Kruijtzer, J.A.W.; Hofmeyer, L.J.F.; Heerma, W.; Versluis, C; Liskamp R.M.J. Solid-phase syntheses of peptoids using fmoc-protected N-substituted glycines: the synthesis of (retro) peptoids of leu-enkephalin and substance P. Chem. Eur. J., 1998, 4, 1570-1580.
60. Biron, E.; Chatterjee, J.; Ovadia, O.; Langenegger, D.; Brueggen, J.; Hoyer, D.; Schmid, H.A.; Jelinek, R.; Gilon, C; Hoffman, A.; Kessler, H. Improving oral bioavailability of peptides by multiple N-methylation: somatostatin analogues. Angew. Chem. Int. Ed., 2008, 47(14), 2595-2599.
61. Olsen, C.A. Peptoid-peptide hybrid backbone architectures. Chem. Bio. Chem., 2010, 11(2), 152-160.
62. Patch, J.A.; Barron, A.E. Helical peptoid mimics of magainin-2 amide. J Am Chem Soc 2003, 125(40), 12092-12093.
63. Seurynck, S.L.; Patch, J.A; Barron, A.E. Simple, helical peptoid analogs of lung surfactant protein B. Chem. Biol, 2005, 12(1), 77-88.
64. Statz, A.R.; Meagher, R.J.; Barron, A.E.; Messersmith, P.B. New peptidomimetic polymers for antifouling surfaces. J. Am. Chem. Soc, 2005, 127(22), 7972-7973.
65. Gorske, B.C.; Stringer, J.R.; Bastian, B.L.; Fowler, S.A.; Blackwell, H.E. New strategies for the design of folded peptoids revealed by a survey of noncovalent interactions in model systems. J. Am. Chem. Soc, 2009, 131(45), 16555-16567.
66. Gorske, B.C.; Bastian, B.L.; Geske, G.D.; Blackwell, H.E. Local and tunable n->K* interactions regulate amide isomerism in the peptoid backbone. J. Am. Chem. Soc, 2007, 129(29), 8928-8929.
67. Kruijtzer, J.A.W.; Nijenhuis, W.A.J.; Wanders, N.; Gispen, W.H.; Liskamp, R.M.J.; Adan, R.A.H. Peptoid-peptide hybrids as potent novel melanocortin receptor ligands. J. Med. Chem., 2005, 48(13), 4224-4230.
68. Ross, T.M.; Zuckermann, R.N.; Reinhard, C; Frey II, W.H. Intranasal administration delivers peptoids to the rat central nervous system. Neurosci. Lett., 2008, 439(1), 30-33.
69. Bessalle, R.; Kapitkovsky, A.; Gorea, A.; Shalit, I.; Fridkin, M. All-D-magainin: chirality, antimicrobial activity and proteolytic resistance. FEBS Lett., 1990, 274(1-2), 151-155.
70. Comegna, D.; Benincasa, M.; Gennaro, R.; Izzo, I.; De Riccardis, F. Desin, synthesis and antimicrobial properties of non-hemolytic cationic a-cyclopeptoids. Bioorg. Med. Chem., 2010, 18(5), 2010-2018.
71. Selsted, M.E. Theta-defensins: cyclic antimicrobial peptides produced by binary ligation of truncated alpha-defensins. Curr. Protein Pept. Sci., 2004, 5(5), 365-371.
72. Huang, M.L.; Shin, S.B.; Benson, M.A.; Torres, V.J.; Kirshenbaum, K. A. comparison of linear and cyclic peptoid oligomers as potent antimicrobial agents. ChemMedChem., 2012, 7(1), 114-22.
73. Chongsiriwatana, N.P.; Miller, T.M.; Wetzler, M.; Vakulenko, S.; Karlsson, A.J.; Palecek, S.P.; Mobashery, S.; Barron, A.E. Short alkylated peptoid mimics of antimicrobial lipopeptides. Antimicrob. Agents Chemother., 2011, 55(1), 417-420.
74. Kapoor, R.; Wadman, M.W.; Dohm, M.T.; Czyzewski, A.M.; Spormann, A.M.; Barron, A.E. Antimicrobial peptoids are effective against Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother., 2011, 55(6), 3054-3057.
75. Kapoor, R.; Eimerman, P.R.; Hardy, J.W.; Cirillo, J.D.; Contag C.H.; Barron, A.E. Efficacy of antimicrobial peptoids against Mycobacterium tuberculosis. Antimicrob. Agents Chemother., 2011, 55(6), 3058-3062.
76. Lee, D.L. Hodges, R.S. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S. Biopolymers, 2003, 71(1), 28-48.
77. Oren, Z.; Shai, Y. Mode of action of linear amphipathic alpha-helical antimicrobial peptides. Biopolymers, 1998, 47(6), 451-463.
78. Liu, D.; Choi, S.; Chen, B.; Doerksen, R.J.; Clements, D.J.; Winkler, J.D.; Klein, M.L.; DeGrado, W.F. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew. Chem. Int. Ed., 2004, 43(9), 1158-1162.
79. Maloy, W.L.; Kari, U.P. Structure-activity studies on magainins and other host defense peptides. Biopolymers, 1995, 37(2), 105-122.
80. Tew, G.N.; Liu, D.H.; Chen, B.; Doerksen, R.J.; Kaplan, J.; Carroll, P.J.; Klein, M.L.; DeGrado, W.F. De novo design of biomimetic antimicrobial polymers. Proc Natl Acad Sci USA, 2002, 99(8), 5110-5114.
81. Tang, H.; Doerksen, R.J.; Jones, T.V.; Klein, M.L.; Tew, G.N. Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem. Biol, 2006, 13(4), 427-435.
82. Vemparala, S.; Ivanov, I.; Pophristic, V.; Spiegel, K.; Klein, M.L. Ab initio calculations of intramolecular parameters for a class of arylamide polymers. J. Comput. Chem. 2006, 27(6), 693-700.
83. Pophristic, V.; Vemparala, S.; Ivanov, I.; Liu, Z.W.; Klein, M.L.; DeGrado, W.F. Controlling the shape and flexibility of arylamides: a combined ab initio, ab initio molecular dynamics, and classical molecular dynamics study. J. Phys. Chem. B, 2006, 110(8), 3517-3526.
84. Doerksen, R.J.; Chen, B.; Liu, D.H.; Tew, G.N.; DeGrado, W.F.; Klein, M.L. Controlling the conformation of arylamides: computational studies of intramolecular hydrogen bonds between amides and ethers or thioethers. Chem. Eur. J., 2004, 10(20), 5008-5016.
85. Tang, H.; Doerksen, R.J.; Jones, T.V. Klein, M.L. Tew, G.N. Biomimetic facially amphiphilic antibacterial oligomers with conformationally stiff backbones. Chem. Biol, 2006, 13(4), 427-435.
86. Choia, S.; Isaacsb, A.; Clementsc, D.; Liuc, D.; Kima, H.; Scottc, R.W.; Winklerb, J.D.; DeGrado, W.F. De novo design and in vivo activity of conformationally restrained antimicrobial arylamide foldamers. Proc. Natl. Acad. Sci. USA, 2009, 106(17), 6968-6973.
87. Mensa, B.; Kim, Y.H.; Choi, S.; Scott, R.; Caputo, G.A.; DeGrado, W.F. Antibacterial mechanism of action of arylamide foldamers. Antimicrob. Agents Chemother., 2011, 55(11), 5043-5053.
88. Thaker, H.D.; Sgolastra, F.; Clements, D.; Scott, R.W.; Tew, G.N. Synthetic mimics of antimicrobial peptides from triaryl scaffolds. J. Med. Chem., 2011, 54(7), 2241-2254.
89. Rennie, J.; Arnt, L.; Tang, H.Z.; Nusslein, K.; Tew, G.N. Simple oligomers as antimicrobial peptide mimics. J. Ind. Microbiol. Biotechnol, 2005, 32(7), 296-300.
90. Arnt, L.; Rennie, J.R.; Linser, S.; Willumeit, R.; Tew, G.N. Membrane activity of biomimetic facially amphiphilic antibiotics. J. Phys. Chem. B, 2006, 110(8), 3527-3532.
91. Tew, G.N.; Clements, D.; Tang, H.; Arnt, L.; Scott, R.W. Antimicrobial activity of an abiotic host defense peptidemimic. Biochim. Biophys. Acta, 2006, 1758(9), 1387-1392.
92. Beckloff, N.; Laube, D.; Castro, T.; Furgang, D.; Park, S.; Perlin, D.; Clements, D.; Tang, H.; Scott, R.W.; Tew, G.N.; Diamond, G. Activity of an antimicrobial peptide mimetic against planktonic and biofilm cultures of oral pathogens. Antimicrob. Agents Chemother., 2007, 51(11), 4125-4132.
93. Arnt, L.; Tew, G.N. Conformational changes of facially amphiphilic poly(phenylene ethynylene)s in aqueous solution. Macromolecules, 2004, 37, 1283-1288.
94. Arnt, L.; Tew, G.N. New poly(phenyleneethynylene)s with cationic, facially amphiphilic structures. J. Am. Chem. Soc., 2002, 124(26), 7664-7665.
95. Arnt, L.; Tew, G.N. Cationic facially amphiphilic poly(phenylene ethynylene)s studied at the air-water interface. Langmuir, 2003, 19, 2404-2408.
96. Ishitsuka, Y.; Arnt, L.; Majewski, J.; Frey, S.; Ratajczek, M.; Kjaer, K.; Tew, G.N.; Lee, K.Y.C. Amphiphilic poly(phenyleneethynylene)s can mimic antimicrobial peptide membrane disordering effect by membrane insertion. J. Am. Chem. Soc., 2006, 128(40), 13123-13129.
97. Yang, L.; Gordon, V.D.; Mishra, A.; Som, A.; Purdy, K.R.; Davis, M.A.; Tew, G.N.; Wong, G.C. Synthetic antimicrobial oligomers induce a composition-dependent topological transition in membranes. J. Am. Chem. Soc., 2007, 129(40), 12141-12147.
98. Som, A.; Tew, G.N. Influence of lipid composition on membrane activty of antimicrobial phenylene ethynylene oligomers. J. Phys. Chem. B, 2008, 112(11), 3495-3502.
99. Park, C.B.; Kim, H.S.; Kim, S.C. Mechanism of action of the antimicrobial peptide buforin II: buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun., 1998, 244(1), 253-257.
100. Stiriba, S.E.; Frey, H.; Haag, R. Dendritic polymers in biomedical applications: from potential to clinical use in diagnostics and therapy. Angew. Chem., Int. Ed. Engl., 2002, 41(8), 1329-1334.
101. Thorsteinsson, T.; Loftsson, T.; Masson, M. Soft antibacterial agents. Curr. Med. Chem., 2003, 10(13), 1129-1136.
102. Lienkamp, K.; and Tew, G.N. Synthetic mimics of antimicrobial peptides-A versatile ring-opening metathesis polymerization based platform for the synthesis of selective antibacterial and cell-penetrating polymers. Chem. Eur. J., 2009, 15(44), 11784-11800.
103. Tashiro, T. Antibacterial and bacterium adsorbing macromolecules. Macromol. Mater. Eng., 2001, 286(2), 63-87.
104. Ilker, M.F.; Nusslein, K.; Tew, G.N.; Coughlin, E.B. Tuning the hemolytic and antibacterial activities of amphiphilic polynorbornene derivatives. J. Am. Chem. Soc., 2004, 126(48), 15870-15875.
105. Li, G.J.; Shen, J.R.; Zhu, Y.L. Study of pyridinium-type functional polymers. II. Antibacterial activity of soluble pyridinium-type polymers. J. Appl. Polym. Sci., 1998, 67(10), 1761-1768.
106. Love, J.A.; Morgan, J.P.; Trnka, T.M.; Grubbs, R.H. A practical and highly active ruthenium-based catalyst that effects the cross metathesis of acrylonitrile. Angew. Chem., Int. Ed. Engl, 2002, 41(21), 4035-4037.
107. Kolonko, E.M.; Kiessling, L.L. A polymeric domain that promotes cellular internalization. J. Am. Chem. Soc, 2008, 130(17), 5626-5627.
108. Trnka, T.M.; Grubbs, R.H. The development of L2X2Ru=CHR olefin metathesis catalysts: an organometallic success story. Acc. Chem. Res., 2001, 34(1), 18-29.
109. Buchmeiser, M. R. Homogeneous metathesis polymerization by well-defined group VI and group VIII transition-metal alkylidenes: fundamentals and applications in the preparation of advanced materials. Chem. Rev., 2000, 100(4), 1565-1604.
110. Raguse, T.L.; Porter, E.A.; Weisblum, B.; Gellman, S.H. Structure-activity studies of 14-helical antimicrobial beta-peptides: probing the relationship between conformational stability and antimicrobial potency. J. Am. Chem. Soc, 2002, 124(43), 12774-12785.
111. Schmitt, M.A.; Weisblum, B.; Gellman, S.H. Unexpected relationships between structure and function in a, p-peptides: antimicrobial foldamers with heterogeneous backbones. J. Am. Chem. Soc., 2004, 126(22), 6848-6849.
112. Fernandez-Lopez, S.; Kim, H.S.; Choi, E.C.; Delgado, M.; Granja, J.R.; Khasanov, A.; Kraehenbuehl, K.; Long, G.; Weinberger, D.A.; Wilcoxen, K.M.; Ghadiri, M.R. Antibacterial agents based on the cyclic D,L-alpha-peptide architecture. Nature, 2001, 412(6845), 452-455.
113. Liu, D.H.; Choi, S.; Chen, B.; Doerksen, R.J.; Clements, D.J.; Winkler, J.D.; Klein, M.L.; DeGrado, W.F. Nontoxic membrane-active antimicrobial arylamide oligomers. Angew. Chem., Int. Ed. Engl., 2004, 43(9), 1158-1162.
114. Porter, E.A.; Wang, X.; Lee, H.S.; Weisblum, B.; Gellman, S.H. Transfection of cells by immunoporation. Nature, 2000, 405(6784), 298.
115. van't Hof, W.; Veerman, E.C.I.; Helmerhorst, E.J.; Amerongen, A.V.N. Antimicrobial peptides: properties and applicability. Biol. Chem., 2001, 382(4), 597-619.
116. Gabriel, G.J.; Madkour, A.E.; Dabkowski, J.M. Synthetic mimic of antimicrobial peptide with nonmembrane-disrupting antibacterial properties. Biomacromolecules, 2008, 9(11), 2980-2983.
117. Hua, Y.; Li, X.; Sebti, S.M. Chen, J.; Cai, J. Design and synthesis of AApeptides: A new class of peptide mimics. Bioorg. Med. Chem. Lett., 2011, 21(5), 1469-1471.
118. Padhee, S.; Hu, Y.; Niu, Y.; Bai, G.; Wu, H.; Costanza, F.; West, L.; Harrington, L.; Shaw, L.N.; Cao C; Cai, J. Non-hemolytic a-AApeptides as antimicrobial peptidomimetics. Chem. Commun., 2011, 47(34), 9729-9731.
119. Niu, Y.; Padhee, S.; Wu, H.; Bai, G.; Harrington, L.; Burda, W.N.; Shaw, L.N.; Cao, C; Cai J. Identification of y-AApeptides with potent and broad-spectrum antimicrobial activity. Chem. Commun., 2011, 47(44), 12197-12199.
120. Niu, Y.; Padhee, S.; Wu, H.; Bai, G.; Qiao, Q.; Hu, Y.; Harrington, L.; Burda, W.N.; Shaw, L.N.; Cao, C; Cai, J. Lipo-y-AApeptides as a new class of potent and broad-spectrum antimicrobial agents. J. Med. Chem., 2012, 55(8), 4003-4009.